Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Outcome Of Patients With Acute Myeloid Leukemia/High Risk MDS According To The Kidney Function

Ahmed Malkawi, MD, Ankit Anand, MD, Ali Al-Ameri, MD, Mohamed Abdelfatah, MD, Zeyad Kanaan, MD, Nairmeen Haller, PhD

Blood (2013) 122 (21): 5007.

https://doi.org/10.1182/blood.V122.21.5007.5007

Published: 2013

Journal Articles

Outcome Of Patients With Acute Myeloid Leukemia/High Risk Myelodysplastic Syndrome Based On Bone Mineral Density: Data From a Single center 2000-2012

Ankit Anand, MD, Hussam Al-sharif, MD, Mohamed Abdelfatah, MD, Nairmeen Haller, PhD, Ali Al-Ameri, MD

Blood (2013) 122 (21): 5008.

https://doi.org/10.1182/blood.V122.21.5008.5008

Published: 2013

Journal Articles

Body Mass Index and Uncontrolled DM Impact On Acute Myeloid Leukemia (AML) Outcomes

Mohamed Abdelfatah, MD, Ankit Anand, MD, Zeyad Kanaan, MD, Ali Al-Ameri, MD, Nairmeen Haller, PhD

Blood (2013) 122 (21): 4998.

https://doi.org/10.1182/blood.V122.21.4998.4998

Published: 2013

Journal Articles

Outcome of Acute Myeloid Leukemia AML &High Risk MDS Treated According to the Standard of Care in Community Hospital, Data From Single Center ( 2001–2010)

Ali Al-Ameri, MD, Mohamed Abdelfatah, MD, Zeyad Kanaan, MD, Nairmeen Haller, PhD

Blood (2012) 120 (21): 4796.

https://doi.org/10.1182/blood.V120.21.4796.4796

Published: 2012

Journal Articles

Decitabine and Gemtuzumab Ozogamicin In Patients with Advanced Myelofibrosis

Ali Al-Ameri Al-Ameri, MD, Hagop Kantarjian, MD, Asifa Malik, MD, Xavier Badoux, MD, Michael Andreeff, MD, PhD, Alfonso Quintas-Cardama, MD, Gautam Borthakur, MD

Blood (2010) 116 (21): 5061.

https://doi.org/10.1182/blood.V116.21.5061.5061

Published: 2010

Journal Articles

Opportunistic Infections Are Uncommon with Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP).

Ali Al-Ameri, Hagop Kantarjian, Gautam Borthakur, Erkut Bahceci, Ted Szatrowski, Andrew Damokosh, Jorge Cortes

Blood (2009) 114 (22): 1120.

https://doi.org/10.1182/blood.V114.22.1120.1120

Published: 2009

NARROW

Outcome Of Patients With Acute Myeloid Leukemia/High Risk MDS According To The Kidney Function

Outcome Of Patients With Acute Myeloid Leukemia/High Risk Myelodysplastic Syndrome Based On Bone Mineral Density: Data From a Single center 2000-2012

Body Mass Index and Uncontrolled DM Impact On Acute Myeloid Leukemia (AML) Outcomes

Outcome of Acute Myeloid Leukemia AML &High Risk MDS Treated According to the Standard of Care in Community Hospital, Data From Single Center ( 2001–2010)

Decitabine and Gemtuzumab Ozogamicin In Patients with Advanced Myelofibrosis

Opportunistic Infections Are Uncommon with Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP).

Email alerts

ASH Publications

American Society of Hematology

Outcome Of Patients With Acute Myeloid Leukemia/High Risk MDS According To The Kidney Function

Outcome Of Patients With Acute Myeloid Leukemia/High Risk Myelodysplastic Syndrome Based On Bone Mineral Density: Data From a Single center 2000-2012

Body Mass Index and Uncontrolled DM Impact On Acute Myeloid Leukemia (AML) Outcomes

Outcome of Acute Myeloid Leukemia AML &High Risk MDS Treated According to the Standard of Care in Community Hospital, Data From Single Center ( 2001–2010)

Decitabine and Gemtuzumab Ozogamicin In Patients with Advanced Myelofibrosis

Opportunistic Infections Are Uncommon with Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only